Site name unknown, Nanjing 210002

Phase	Trial	Trial Status	Site Status	Drug [desc]	NCT#
4	Safety And Efficacy Study Of Sunitinib Malate In Chinese Patients With Imatinib Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor (GIST)	Completed	Closed	Sunitinib	NCT00793871